Cargando…
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature
PURPOSE: Post-neurosurgical infection caused by extensively drug resistant Pseudomonas aeruginosa (XDR-PA) are becoming a matter of great concern due to limited therapeutic options. Although not approved for these indications, the new BetaLactam-BetaLactamase Inhibitor combinations (BLBLIs) could re...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569357/ https://www.ncbi.nlm.nih.gov/pubmed/33074365 http://dx.doi.org/10.1007/s15010-020-01539-9 |
_version_ | 1783596713748987904 |
---|---|
author | Meschiari, Marianna Franconi, Iacopo Bacca, Erica Bianco, Vincenzo Orlando, Gabriella Cuomo, Gianluca Bedini, Andrea Mussini, Cristina |
author_facet | Meschiari, Marianna Franconi, Iacopo Bacca, Erica Bianco, Vincenzo Orlando, Gabriella Cuomo, Gianluca Bedini, Andrea Mussini, Cristina |
author_sort | Meschiari, Marianna |
collection | PubMed |
description | PURPOSE: Post-neurosurgical infection caused by extensively drug resistant Pseudomonas aeruginosa (XDR-PA) are becoming a matter of great concern due to limited therapeutic options. Although not approved for these indications, the new BetaLactam-BetaLactamase Inhibitor combinations (BLBLIs) could represent a valid salvage treatment. We describe one nosocomial meningitis and two cervical osteomyelitis due to an XDR-PA who were treated with ceftazidime/avibactam (CZA) and ceftolozane/tazobactam (C/T) and review the literature. METHODS: The first and the third patients developed an osteomyelitis following cervical stabilization surgery due to an XDR-PA. Although the first patient started treatment with a high dose of C/T, resistance to C/T occurred, so therapy was switched to CZA plus aztreonam. The third patient switched to aztreonam plus CZA due to development of acute kidney injury during therapy with colistin. The second patient had an XDR-PA meningitis following the insertion of an external ventricular catheter and he was treated with C/T plus meropenem and amikacin. RESULTS: All three cases reported were successfully conservatively treated thanks to the use of the new BLBLIs with different combinations. Only few experiences demonstrated an equally favorable outcome: one patient treated with C/T plus fosfomycin for otogenic meningitis caused by an XDR-PA and another case of XDR-PA post-surgical meningitis with CZA in combination with colistin. Finally, the combination of CZA plus aztreonam has proven to be effective on XDR-PA only in limited mostly in vitro studies. CONCLUSION: These recently developed antibiotics, C/T and CZA are promising and complementary therapy options against post-neurosurgical hard-to-treat P. aeruginosa infections. Further prospective real-life studies are required to validate these findings in this special setting. |
format | Online Article Text |
id | pubmed-7569357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-75693572020-10-19 Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature Meschiari, Marianna Franconi, Iacopo Bacca, Erica Bianco, Vincenzo Orlando, Gabriella Cuomo, Gianluca Bedini, Andrea Mussini, Cristina Infection Case Report PURPOSE: Post-neurosurgical infection caused by extensively drug resistant Pseudomonas aeruginosa (XDR-PA) are becoming a matter of great concern due to limited therapeutic options. Although not approved for these indications, the new BetaLactam-BetaLactamase Inhibitor combinations (BLBLIs) could represent a valid salvage treatment. We describe one nosocomial meningitis and two cervical osteomyelitis due to an XDR-PA who were treated with ceftazidime/avibactam (CZA) and ceftolozane/tazobactam (C/T) and review the literature. METHODS: The first and the third patients developed an osteomyelitis following cervical stabilization surgery due to an XDR-PA. Although the first patient started treatment with a high dose of C/T, resistance to C/T occurred, so therapy was switched to CZA plus aztreonam. The third patient switched to aztreonam plus CZA due to development of acute kidney injury during therapy with colistin. The second patient had an XDR-PA meningitis following the insertion of an external ventricular catheter and he was treated with C/T plus meropenem and amikacin. RESULTS: All three cases reported were successfully conservatively treated thanks to the use of the new BLBLIs with different combinations. Only few experiences demonstrated an equally favorable outcome: one patient treated with C/T plus fosfomycin for otogenic meningitis caused by an XDR-PA and another case of XDR-PA post-surgical meningitis with CZA in combination with colistin. Finally, the combination of CZA plus aztreonam has proven to be effective on XDR-PA only in limited mostly in vitro studies. CONCLUSION: These recently developed antibiotics, C/T and CZA are promising and complementary therapy options against post-neurosurgical hard-to-treat P. aeruginosa infections. Further prospective real-life studies are required to validate these findings in this special setting. Springer Berlin Heidelberg 2020-10-19 2021 /pmc/articles/PMC7569357/ /pubmed/33074365 http://dx.doi.org/10.1007/s15010-020-01539-9 Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Case Report Meschiari, Marianna Franconi, Iacopo Bacca, Erica Bianco, Vincenzo Orlando, Gabriella Cuomo, Gianluca Bedini, Andrea Mussini, Cristina Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature |
title | Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature |
title_full | Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature |
title_fullStr | Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature |
title_full_unstemmed | Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature |
title_short | Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature |
title_sort | ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569357/ https://www.ncbi.nlm.nih.gov/pubmed/33074365 http://dx.doi.org/10.1007/s15010-020-01539-9 |
work_keys_str_mv | AT meschiarimarianna ceftazidimeavibactamandceftolozanetazobactamforthetreatmentofextensivelydrugresistantpseudomonasaeruginosapostneurosurgicalinfectionsthreecasesandareviewoftheliterature AT franconiiacopo ceftazidimeavibactamandceftolozanetazobactamforthetreatmentofextensivelydrugresistantpseudomonasaeruginosapostneurosurgicalinfectionsthreecasesandareviewoftheliterature AT baccaerica ceftazidimeavibactamandceftolozanetazobactamforthetreatmentofextensivelydrugresistantpseudomonasaeruginosapostneurosurgicalinfectionsthreecasesandareviewoftheliterature AT biancovincenzo ceftazidimeavibactamandceftolozanetazobactamforthetreatmentofextensivelydrugresistantpseudomonasaeruginosapostneurosurgicalinfectionsthreecasesandareviewoftheliterature AT orlandogabriella ceftazidimeavibactamandceftolozanetazobactamforthetreatmentofextensivelydrugresistantpseudomonasaeruginosapostneurosurgicalinfectionsthreecasesandareviewoftheliterature AT cuomogianluca ceftazidimeavibactamandceftolozanetazobactamforthetreatmentofextensivelydrugresistantpseudomonasaeruginosapostneurosurgicalinfectionsthreecasesandareviewoftheliterature AT bediniandrea ceftazidimeavibactamandceftolozanetazobactamforthetreatmentofextensivelydrugresistantpseudomonasaeruginosapostneurosurgicalinfectionsthreecasesandareviewoftheliterature AT mussinicristina ceftazidimeavibactamandceftolozanetazobactamforthetreatmentofextensivelydrugresistantpseudomonasaeruginosapostneurosurgicalinfectionsthreecasesandareviewoftheliterature |